ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Asia

Philippines approves China's Sinovac COVID-19 vaccine as booster shots

Manila [Philippines], November 16 (ANI/Xinhua): The Philippines' Food and Drug Administration (FDA) has approved the use of China's Sinovac CoronaVac vaccine and three other brands as booster shots against the COVID-19, FDA Director General Enrique Domingo said Tuesday.

ANI Nov 16, 2021 21:16 IST googleads

Representative Image

Manila [Philippines], November 16 (ANI/Xinhua): The Philippines' Food and Drug Administration (FDA) has approved the use of China's Sinovac CoronaVac vaccine and three other brands as booster shots against the COVID-19, FDA Director General Enrique Domingo said Tuesday.
During a pre-recorded meeting aired on Tuesday, Domingo said the FDA has already amended the emergency use authorization of Sinovac, Pfizer, AstraZeneca and Sputnik Light, "meaning six months after the second dose, another can be administered."
The Philippines' Department of Health (DOH) said that all fully vaccinated healthcare workers could get the booster doses starting on Wednesday, as well as people with underlying health conditions and the elderly with comorbidities.
To date, the Philippines has received almost 125 million doses of COVID-19 vaccines from different vaccine makers. China, the biggest supplier of COVID-19 vaccines, was the first country to provide vaccines to the Philippines, allowing the Southeast Asian country to kick off its vaccination drive on March 1.
The Philippines has administered nearly 71 million doses of COVID-19 vaccines. More than 31.8 million people have been fully vaccinated. The government aims to vaccinate up to 70 per cent of its 110 million population this year.
As of Tuesday, the country has reported a total of nearly 2.82 million confirmed cases of COVID-19, including 45,808 deaths. (ANI/Xinhua)

Get the App

What to Read Next

Asia

India consistently supported Maldives in crisis: Mohamed Nasheed

India consistently supported Maldives in crisis: Mohamed Nasheed

He highlighted India's role as a "first responder" for the Maldives, emphasising that India's support during critical periods has been fundamental to the stability and security of the island nation.

Read More
Asia

Policy delays leave Pakistan short of critical medicines

Policy delays leave Pakistan short of critical medicines

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Read More
Europe

EU ambs approve new sanctions on 19 Iranian officials, entities

EU ambs approve new sanctions on 19 Iranian officials, entities

The European Union on Wednesday moved to intensify pressure on Tehran amid the conflict in West Asia by approving new sanctions targeting 19 Iranian regime officials and entities accused of serious human rights violations.

Read More
Asia

Killings of three men in Panjgur trigger outrage in Balochistan

Killings of three men in Panjgur trigger outrage in Balochistan

Three young men were shot dead in Balochistan's Panjgur district, allegedly by state-backed "death squads." The Baloch Yakjehti Committee condemned the killings alongside recent attacks on intellectuals and artists, urging the UN to investigate these escalating human rights violations and targeted violence across the province.

Read More
Asia

Balen Shah’s RSP heads for landslide victory in Nepal polls

Balen Shah’s RSP heads for landslide victory in Nepal polls

Balen Shah's RSP is heading for a landslide victory in Nepal's parliamentary polls, leading in 98 seats and winning 19. Shah holds a massive lead over veteran KP Sharma Oli, as the RSP nears a simple majority, with party leaders eyeing a two-third majority of 186 seats.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.